Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study.

PubWeight™: 1.78‹?› | Rank: Top 3%

🔗 View Article (PMID 26298428)

Published in Nutr Metab Cardiovasc Dis on July 29, 2015

Authors

J N Kiage1, U K A Sampson2, L Lipworth3, S Fazio4, G A Mensah5, Q Yu6, H Munro7, E A Akwo8, Q Dai9, W J Blot10, E K Kabagambe11

Author Affiliations

1: Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA. Electronic address: kiagejn@gmail.com.
2: Center for Translation Research and Implementation Science (CTRIS), National Heart, Lung, and Blood Institute, Bethesda, MD 30105, USA. Electronic address: uchechukwu.sampson@nih.gov.
3: Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Vanderbilt Center for Translational and Clinical Cardiovascular Research, Vanderbilt University Medical Center, Nashville, TN 37203, USA. Electronic address: loren.lipworth@vanderbilt.edu.
4: The Knight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health and Science University, Portland, OR 97239, USA. Electronic address: fazio@ohsu.edu.
5: Center for Translation Research and Implementation Science (CTRIS), National Heart, Lung, and Blood Institute, Bethesda, MD 30105, USA. Electronic address: george.mensah@nih.gov.
6: Westat, Rockville, MD 20850, USA. Electronic address: qiluyu@westat.com.
7: The International Epidemiology Institute, Rockville, MD 20850, USA. Electronic address: heather@iei.us.
8: Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Vanderbilt Center for Translational and Clinical Cardiovascular Research, Vanderbilt University Medical Center, Nashville, TN 37203, USA. Electronic address: elvis.a.akwo@vanderbilt.edu.
9: Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA. Electronic address: qi.dai@vanderbilt.edu.
10: Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; The International Epidemiology Institute, Rockville, MD 20850, USA. Electronic address: william.j.blot@vanderbilt.edu.
11: Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Vanderbilt Center for Translational and Clinical Cardiovascular Research, Vanderbilt University Medical Center, Nashville, TN 37203, USA. Electronic address: edmond.kabagambe@vanderbilt.edu.

Articles cited by this

Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr (1997) 11.07

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation (2002) 9.02

Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension (2008) 7.99

n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med (2010) 7.58

n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med (2013) 7.24

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation (2002) 4.56

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79

Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials. Hypertension (2007) 3.40

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20

The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved (2010) 2.44

Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med (2008) 2.24

Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med (1993) 1.65

Estimating nutrient intake from a food frequency questionnaire: incorporating the elements of race and geographic region. Am J Epidemiol (2009) 1.53

Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study. N Engl J Med (1990) 1.39

Statins and cardioprotection--more than just lipid lowering? Pharmacol Ther (2009) 1.27

Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem (2007) 1.17

The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr (2002) 1.15

Relationship of dietary linoleic acid to blood pressure. The International Study of Macro-Micronutrients and Blood Pressure Study [corrected]. Hypertension (2008) 1.14

Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr (2003) 1.14

Fish oil, selenium and mercury in relation to incidence of hypertension: a 20-year follow-up study. J Intern Med (2011) 1.11

Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort study. Am J Cardiol (2012) 1.10

Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese European young adults during energy restriction. Nutrition (2009) 1.06

Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis (2010) 1.01

Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension (1993) 1.01

Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr (2008) 0.99

Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr (2013) 0.96

Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol (1992) 0.96

Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study. Circ Cardiovasc Qual Outcomes (2013) 0.96

n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr (1997) 0.95

Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension (1999) 0.94

Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension (2010) 0.91

Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? BMC Med (2013) 0.88

Is fatty acid intake a predictor of arterial stiffness and blood pressure in men? Evidence from the Caerphilly Prospective Study. Nutr Metab Cardiovasc Dis (2013) 0.86

Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects? Expert Rev Cardiovasc Ther (2010) 0.86

Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr (2014) 0.85

The antihypertensive actions of statins: modulation by salt intake. Am J Hypertens (2012) 0.84

Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction. Vasc Health Risk Manag (2007) 0.82

A prospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States. Clin Epidemiol (2013) 0.80